Programme of the Community Network of Reference Laboratories for Human Influenza to Improve Influenza Surveillance in Europe

被引:12
作者
Meijer, Adam
Brown, Caroline
Hungnes, Olav
Schweiger, Brunhilde
Valette, Martine
van der Werf, Sylvie
Zambon, Maria
机构
[1] NIVEL, European Influenza Surveillance Scheme Coordinat, NL-3513 CR Utrecht, Netherlands
[2] Natl Inst Publ Hlth & Environm, Diagnost Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands
[3] Norwegian Inst Publ Hlth, NIC, Oslo, Norway
[4] Robert Koch Inst, NIC, D-1000 Berlin, Germany
[5] Hosp Civils Lyon, Virol Lab, NIC Reg Sud, Lyon, France
[6] Inst Pasteur, NIC Reg N, Paris, France
[7] ERNVL, Hlth Protect Agcy, NIC, Resp Virus Unit, London, England
关键词
influenza; laboratory network; European Influenza Surveillance Scheme;
D O I
10.1016/j.vaccine.2006.05.068
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
All laboratories participating in the Community Network of Reference Laboratories for Human Influenza in Europe (CNRL) co-ordinated by the European Influenza Surveillance Scheme (EISS) should be able to perform a range of influenza diagnostics. This includes direct detection, culture, typing, subtyping and strain characterisation of influenza viruses, diagnostic serology and the creation of archives for clinical specimens and virus isolates. To improve the capacity and quality of the laboratories of the CNRL and to increase the consistency in performance among all 25 European Union countries plus Norway, Romania, and Switzerland, five task groups were set up in February 2005. These task groups developed work programmes in the areas of virus isolation, antibodies, molecular virology, quality control assessment and antiviral susceptibility testing. This report outlines the programmes and the results achieved in the first half-year of operation of the task groups. The action plans are challenging and it is expected that these efforts will lead to considerable improvements in the performance of the laboratories and in the standardisation of methods employed in Europe with regard to routine influenza surveillance and early warning for emerging viruses. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6717 / 6723
页数:7
相关论文
共 19 条
[1]   The evolution of influenza surveillance in Europe and prospects for the next 10 years [J].
Fleming, DM ;
van der Velden, J ;
Paget, WJ .
VACCINE, 2003, 21 (16) :1749-1753
[2]   COMPARISON OF DIFFERENT TISSUE-CULTURES FOR ISOLATION AND QUANTITATION OF INFLUENZA AND PARA-INFLUENZA VIRUSES [J].
FRANK, AL ;
COUCH, RB ;
GRIFFIS, CA ;
BAXTER, BD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1979, 10 (01) :32-36
[3]   Resistant influenza A viruses in children treated with oseltarnivir: descriptive study [J].
Kiso, M ;
Mitamura, K ;
Sakai-Tagawa, Y ;
Shiraishi, K ;
Kawakami, C ;
Kimura, K ;
Hayden, FG ;
Sugaya, N ;
Kawaoka, Y .
LANCET, 2004, 364 (9436) :759-765
[4]   Overexpression of the α-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors [J].
Matrosovich, M ;
Matrosovich, T ;
Carr, J ;
Roberts, NA ;
Klenk, HD .
JOURNAL OF VIROLOGY, 2003, 77 (15) :8418-8425
[5]  
Meerhoff T J, 2004, Euro Surveill, V9, P34
[6]   Harmonising the virological surveillance of influenza in Europe: results of an 18-country survey [J].
Meerhoff, TJ ;
Paget, WJ ;
Aguilera, JF ;
van der Velden, J .
VIRUS RESEARCH, 2004, 103 (1-2) :31-33
[7]  
MEGURO H, 1979, J CLIN MICROBIOL, V9, P175
[8]   Measurement of antibodies to avian influenza virus A(H7N7) in humans by hemagglutination inhibition test [J].
Meijer, A ;
Bosman, A ;
van de Kamp, EEHM ;
Wilbrink, B ;
Holle, MDR ;
Koopmans, M .
JOURNAL OF VIROLOGICAL METHODS, 2006, 132 (1-2) :113-120
[9]   Implementation of the community network of reference laboratories for human influenza in Europe [J].
Meijer, A ;
Valette, M ;
Manuguerra, JC ;
Pérez-Breña, P ;
Paget, J ;
Brown, C ;
van der Velden, K .
JOURNAL OF CLINICAL VIROLOGY, 2005, 34 (02) :87-96
[10]   Highly pathogenic avian influenza virus A(H7N7) infection of humans and human-to-human transmission during avian influenza outbreak in the Netherlands [J].
Meijer, A ;
Wilbrink, B ;
Holle, MDV ;
Fouchier, RAM ;
Natrop, G ;
Bosman, A ;
Osterhaus, ADME ;
van Steenbergen, JE ;
Conyn-van Spaendonck, MAE ;
Koopmans, M .
OPTIONS FOR THE CONTROL OF INFLUENZA V, 2004, 1263 :65-68